The Role of Immunotherapy in Pancreatic Cancer. [Review] (Record no. 155)

MARC details
000 -LEADER
fixed length control field 02355nam a22004457a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 221213s20222022 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1198-0052
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.3390/curroncol29100541 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code curroncol29100541 [pii]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC9600738 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 36290818
245 ## - TITLE STATEMENT
Title The Role of Immunotherapy in Pancreatic Cancer. [Review]
251 ## - Source
Source Current Oncology. 29(10):6864-6892, 2022 Sep 23.
252 ## - Abbreviated Source
Abbreviated source Curr. oncol.. 29(10):6864-6892, 2022 Sep 23.
253 ## - Journal Name
Journal name Current oncology (Toronto, Ont.)
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2023
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Publication date 2022 Sep 23
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
266 ## - Date added to catalog
Date added to catalog 2022-12-13
501 ## - WITH NOTE
Local holdings Available online through MWHC library: 2006 - present
520 ## - SUMMARY, ETC.
Abstract Pancreatic adenocarcinoma remains one of the most lethal cancers globally, with a significant need for improved therapeutic options. While the recent breakthroughs of immunotherapy through checkpoint inhibitors have dramatically changed treatment paradigms in other malignancies based on considerable survival benefits, this is not so for pancreatic cancer. Chemotherapies with modest benefits are still the cornerstone of advanced pancreatic cancer treatment. Pancreatic cancers are inherently immune-cold tumors and have been largely refractory to immunotherapies in clinical trials. Understanding and overcoming the current failures of immunotherapy through elucidating resistance mechanisms and developing novel therapeutic approaches are essential to harnessing the potential durable benefits of immune-modulating therapy in pancreatic cancer patients.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Adenocarcinoma
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Pancreatic Neoplasms
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunologic Factors
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pancreatic Neoplasms/dt [Drug Therapy]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pancreatic Neoplasms/pa [Pathology]
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Internal Medicine Residency
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
657 ## - INDEX TERM--FUNCTION
Medline publication type Review
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Debnath, Dipanjan
Institution Code MWHC
Program Internal Medicine Residency
Degree MBBS
Resident year Resident PGY 3
790 ## - Authors
All authors Debnath D, Hartley ML, Mukherji R, Noel MS
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.3390/curroncol29100541">https://dx.doi.org/10.3390/curroncol29100541</a>
Public note https://dx.doi.org/10.3390/curroncol29100541
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 12/13/2022   36290818 36290818 12/13/2022 12/13/2022 Journal Article

Powered by Koha